TRDA Live signaler | Maksimer profitt med Getagraph.com

KJøP 118617 min ago

@ $14.49

Utstedt: 13 feb 2024 @ 15:30

Avkastning: -9.18%

Forrige signal: feb 7 - 15:30

Forrige signal: Selg

Avkastning: 1.26 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases...

Stats
Dagens volum	38 162.00
Gjennomsnittsvolum	79 226.00
Markedsverdi	442.19M
EPS	$0 ( 2024-03-18 )
Neste inntjeningsdato	( $-0.380 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-65.80
ATR14	$0.0680 (0.52%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-08	Kim Peter S	Buy	2 600	Common Stock
2024-03-28	Kim Peter S	Buy	1 512	Common Stock
2024-03-26	Kim Peter S	Buy	2 750	Common Stock
2024-03-25	Kim Peter S	Buy	3 180	Common Stock
2024-03-22	Kim Peter S	Buy	3 118	Common Stock

INSIDER POWER
70.19
Last 99 transactions
Buy: 995 092 \| Sell: 209 386

Volum Korrelasjon

Lang: 0.27 (neutral)

Kort: -0.04 (neutral)

Signal:(53.214) Neutral

Entrada Therapeutics, Korrelasjon

10 Mest positive korrelasjoner
GXGX	0.876
MTP	0.872
HOL	0.871
PEV	0.864
IMGN	0.861
EPSN	0.85
PLIN	0.847
THCB	0.842
LGMK	0.839
CBIO	0.839

10 Mest negative korrelasjoner
RAVN	-0.874
CSPI	-0.853
NECB	-0.85
CREC	-0.848
TBSAU	-0.848
GHIX	-0.846
HOFT	-0.842
ENTF	-0.842
FICV	-0.842
IVAC	-0.839

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Entrada Therapeutics, Korrelasjon - Valuta/Råvare

0.71
( moderate )

0.24
( neutral )

0.00
( neutral )

-0.01
( neutral )

-0.63
( weak negative )

Entrada Therapeutics, Økonomi

Annual	2023
Omsetning:	$129.01M
Bruttogevinst:	$126.17M (97.80 %)
EPS:	$-0.200

FY	2023
Omsetning:	$129.01M
Bruttogevinst:	$126.17M (97.80 %)
EPS:	$-0.200

FY	2022
Omsetning:	$0
Bruttogevinst:	$-1.90M (0.00 %)
EPS:	$-2.79

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.97

Financial Reports:

No articles found.

Entrada Therapeutics,

Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Sanntidsoppdatering for Entrada Therapeutics, [TRDA]

Upcoming Earnings Alert